HIGH PERFORMANCE (OTCMKTS:TBEV) reported a definitive date for the formal start of production for High Performance Sports Beverage. The company stated that after considering all the factors and taking into account all entities involved with the making, bottling and marketing of its product, the official production date for its High Performance Sports Beverages is June 29, 2015.
The expert comments
Mike Holley, the President of High Performance Beverage, expressed that the company invested many months of preparation into setting up the best alliances so as to finally launch product to market under brand name, the ‘High Performance Beverage.’ The team is extremely confident that once sports beverage are made available to the retail customers, the company will record rapid growth and distribution in the U.S
The President further added that the beverage will right away become available for retail sale via company’s website. The company is initiating several lines of distribution on both West and East coasts. The plan is to expand sales exposure through multiple retail sites through an internet presence. Moreover, High Performance plans to award all Sweepstakes winners in the very first week of production.
HIGH PERFORMANCE (OTCMKTS:TBEV) also reported that filed an amendment to its 10K/A submitted on January 23, 2015. The objective of this recent amendment is to include additional clarification and explanation to the details of the change in compensation costs for the year ended July 31, 2014 mentioned in Part II, Item 7, under Management’s Discussion and Analysis. The clarification reflects an accurate accounting of compensation disbursement and should resolve any doubts as to what the Officers are being reimbursed or compensated.
In last trading session, the stock price of High Performance declined more than 16% to close the trading session at $0.00050. The decline came at a share volume of 93.91 million compared to average share volume of 167.23 million.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: